WeightWatchers Moves Into the Ozempic Market With Telehealth Deal

  • 📰 WSJhealth
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 53%

Business News News

Business Business Latest News,Business Business Headlines

WeightWatchers makes a move into the controversial market for diabetes and obesity drugs including Ozempic

Sequence is a subscription service that offers telehealth visits with doctors who can prescribe the drugs. WeightWatchers, which has long promised to help customers lose weight through food-tracking and lifestyle changes, is moving to also offer customers a medical weight-loss approach.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 413. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WSJ News Exclusive | WeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors. Isn't moving into the Ozempic market an implicit admission that their product doesn't work. 'You can totally lose weight and keep it off with our points system... but on second thought, here's some drugs.' 황금으로 만든 골든 이글이 필요해
Source: WSJhealth - 🏆 413. / 53 Read more »